These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 26514998

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection.
    Nguyen J, Barritt AS, Jhaveri R.
    J Pediatr; 2019 Apr; 207():90-96. PubMed ID: 30738661
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial.
    Lim AG, Aas CF, Çağlar ES, Vold JH, Fadnes LT, Vickerman P, Johansson KA.
    Addiction; 2023 Dec; 118(12):2424-2439. PubMed ID: 37515462
    [Abstract] [Full Text] [Related]

  • 6. Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model.
    Scott N, McBryde ES, Thompson A, Doyle JS, Hellard ME.
    Gut; 2017 Aug; 66(8):1507-1515. PubMed ID: 27196586
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
    Kim KA, Chung W, Choi HY, Ki M, Jang ES, Jeong SH.
    Liver Int; 2019 Jan; 39(1):60-69. PubMed ID: 29998565
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States.
    Tatar M, Keeshin SW, Mailliard M, Wilson FA.
    JAMA Netw Open; 2020 Sep 01; 3(9):e2015756. PubMed ID: 32880650
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis.
    Ciaccio A, Cortesi PA, Bellelli G, Rota M, Conti S, Okolicsanyi S, Rota M, Cesana G, Mantovani LG, Annoni G, Strazzabosco M.
    Liver Int; 2017 Jul 01; 37(7):982-994. PubMed ID: 27943549
    [Abstract] [Full Text] [Related]

  • 19. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings.
    Assoumou SA, Tasillo A, Leff JA, Schackman BR, Drainoni ML, Horsburgh CR, Barry MA, Regis C, Kim AY, Marshall A, Saxena S, Smith PC, Linas BP.
    Clin Infect Dis; 2018 Jan 18; 66(3):376-384. PubMed ID: 29020317
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.